Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 20
Summary
- Conditions
- Cardiovascular Disease
- HIV
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Investigator)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 40 years and 59 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT02272946
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Priscilla Hsue, MD University of California, San Francisco